X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,445 | – | 10,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |